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AMP-activated protein kinase (AMPK) is an evolu-
tionarily conserved metabolic sensor that responds
to alterations in cellular energy levels to maintain
energy balance. While its role in metabolic homeo-
stasis is well documented, its role in mammalian
development is less clear. Here we demonstrate
that mutant mice lacking the regulatory AMPK b1
subunit have profound brain abnormalities. The
b1/ mice show atrophy of the dentate gyrus and
cerebellum, and severe loss of neurons, oligoden-
drocytes, and myelination throughout the central
nervous system. These abnormalities stem from
reduced AMPK activity, with ensuing cell cycle
defects in neural stem and progenitor cells (NPCs).
The b1/ NPC deficits result from hypophosphory-
lation of the retinoblastoma protein (Rb), which is
directly phosphorylated by AMPK at Ser804. The
AMPK-Rb axis is utilized by both growth factors
and energy restriction to increase NPC growth. Our
results reveal that AMPK integrates growth factor
signaling with cell cycle control to regulate brain
development.
INTRODUCTION
AMP-activated protein kinase (AMPK) is an integrative metabolic
sensor that maintains energy balance at both the cellular and
systemic level. It links neuronal functions with energy supply,
and plays a key role in hypothalamic control of food intake and
peripheral energy expenditure (Xue and Kahn, 2006). Systemic
AMPK activity is linked to human diseases, such as diabetes,
obesity, stroke, hypertension, myocardial injury, and atheroscle-
rosis, and may be involved in the protection afforded by caloric
restriction (Claret et al., 2007; Miller et al., 2008; Dyck, 2007).
One important neuronal target of AMPK is the GABAB receptor,
the activation of which helps mediate neuroprotection after
ischemia (Kuramoto et al., 2007).
In addition to its metabolic functions, studies in model organ-
isms suggest that AMPK also regulates cell structure and
polarity, cell division, as well as normal growth and development256 Developmental Cell 16, 256–270, February 17, 2009 ª2009 Else(Lee et al., 2007; Baena-Gonza´lez et al., 2007). In particular,
AMPK helps maintain genomic integrity in neural precursors,
as well as the structure and function of mature neurons in
Drosophila (Lee et al., 2007). Loss of AMPK activity causes neu-
rodegeneration in Drosophila (Tscha¨pe et al., 2002; Spasic´ et al.,
2008) and AMPK activation in mice protects hippocampal
neurons against metabolic, excitotoxic and oxidative insults
(Culmsee et al., 2001). These studies have suggested that
AMPK may have additional roles beyond the established meta-
bolic functions, both in normal physiology and disease.
AMPK is a heterotrimeric, multisubstrate kinase composed of
one catalytic (a1 or a2), one regulatory (b1 or b2), and one AMP/
ATP binding (g1, g2, or g3) subunit. The C terminus of the
b subunit interacts with both a and g subunits, and current
biochemical and structural evidence indicate that the b subunit
is an obligatory component of the active AMPK complex.
When intracellular energy levels drop (low ATP:AMP ratio),
AMP displaces ATP from the g subunit, causing a conformational
change that allows upstream kinases (e.g., LKB1 or CaMKKb) to
phosphorylate and activate the a subunit. In addition to uniting
the a and g subunits, in yeast the b subunits also serve regulatory
functions, as they direct the AMPK complex to defined
substrates in specific subcellular compartments (Vincent et al.,
2001).
The analysis of mice lacking AMPKa1 or -a2 catalytic subunits
has demonstrated the widespread and overlapping functions of
these proteins, and the importance of overall AMPK activity (Jør-
gensen et al., 2005). Human mutations of the g2 subunit cause
cardiomyopathy, characterized by hypertrophy and glycogen
accumulation (Blair et al., 2001), whereas characterization of
mice lacking g3 subunit has demonstrated impaired postexer-
cise glycogen resynthesis in skeletal muscle (Barnes et al.,
2004). In contrast to studies of these subunits, little is known
about the physiologic roles of individual b subunits in mammals.
Interestingly, loss of AMPKb subunit in Drosophila causes
progressive neurodegeneration, indicating a crucial role in adult
neuron maintenance (Spasic´ et al., 2008). To investigate how
b subunits regulate the physiologic functions of AMPK in
mammals, we generated AMPKb1/ mice. Our results demon-
strate that the AMPKb1 subunit is crucial for proper brain devel-
opment through its regulation of AMPK phosphorylation of
retinoblastoma protein (Rb), a pathway that provides for the
integration of nutrient and growth factor signaling pathways
that influence neural differentiation.vier Inc.
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AMPK Regulates Mammalian Brain DevelopmentFigure 1. AMPKb1-Deficient Mice Show Reduced AMPK Activity and Manifest Brain Abnormalities
(A and B) (A) Immunoblot analysis of WT (+/+) and b1/ brain lysates using b1/b2 C-terminal antibodies or (B) total or phosphorylated AMPK (AMPKThr172) and
ACC (ACCSer79) antibodies (n = 4 independent experiments).
(C) Densitometric analysis of bands in (A) and (B).
(D) Macroscopic view of WT and b1/brain at P14 (lower panel and outlined by dotted line in upper panel) in b1/ mice. CB, cerebellum; IC, inferior colliculi; SC,
superior colliculi.
(E and F) Coronal brain sections showing atrophy of (E) dentate gyrus (arrow) and (F) cerebellum. IGL, inner granule cell layer.
(G and H) NeuN immunohistochemistry of (G) cortex and dentate gyrus (arrow) and (H) cerebellum.
(I) Quantification of neuronal losses assessed by counting NeuN+ cells; *p < 0.001 (n = 5). Error bars indicate SD.RESULTS
Generation of AMPKb1 Mutant Mice
To investigate the biologic roles of the AMPK b1 subunit, we
generated mutant mice using embryonic stem (ES) cells in which
the b1 gene was interrupted by the insertion of a bgeo cassette
(henceforth referred to as b1/ mice). The insertion created
a b1-bgeo fusion protein containing exons 1–5 of b1. This
produces a mutant b1 protein lacking the terminal 46 amino
acids (see Figure S1A available online). This deleted domain is
required for generation of the active AMPK heterotrimer through
interactions with both a and g subunits, and is highly conserved
in the closely related AMPKb2 protein (Iseli et al., 2005). We
confirmed the existence of a single bgeo integrant at the pre-
dicted site in the b1 locus by Southern blot analysis, PCR geno-
typing, RT-PCR analysis, and nucleotide sequencing (Figures
S1B–S1D). We detected the b1-bgeo fusion protein by immuno-
blotting with a b-gal antibody in lysates from multiple tissues,
including brain (Figure S1E). The absence of wild-type (WT) b1
in lysates from b1-deficient E14.5 telencephalon (forebrain), P7
cerebellum (Figure 1A), and mouse embryonic fibroblastDevelop(MEFs) (Figure S1F) was confirmed using a b1/b2 C-terminal-
specific antibody. The loss of b1 caused a significant reduction
of activated AMPK (phospho-AMPKaThr172) and phosphorylated
acetyl CoA carboxylase (phospho-ACCSer79), a downstream
target of AMPK, in the brain and other organs (Figures 1B and
1C; Figures S1G–S1I; and data not shown). A similar reduction
in AMPK activity was observed by monitoring phosphorylation
of the AMPK artificial substrate (SAMS peptide) (data not
shown).
AMPKb1/ Mice Display Structural and Functional
Brain Abnormalities
The b1/ mutant mice were born in a proper Mendelian ratio,
but failed to gain weight normally, and were clearly emaciated
by Postnatal Day 14 (P14) (Figure S2 and Movie S1). They dis-
played severe tremors, ataxic gait, and seizure-like activity and
died by P21. Most notably, an examination of P14 b1/ animals
revealed a 50% reduction in overall brain size, with severe cere-
bellar atrophy and marked reduction of the cerebral cortex, re-
sulting in improper cortical fusion and exposure of the superior
and inferior colliculi (Figure 1D; Figure S3A). A histologicalmental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc. 257
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(Figure 1E). The cerebellum was characterized by loss of the
inner granule cell layer (IGL), extensive spongiform vacuolation,
and disordered laminar organization (Figure 1F). We did not
observe abnormalities in brain structure or behavior in b1+/
animals.
To further characterize the extent of neuronal loss, we used
the NeuN antibody to perform immunohistochemistry on brain
sections. Significant losses (between 35 and 65%) of cortical
neurons and granule neurons of the dentate gyrus (Figure 1G)
and IGL of the cerebellum were clearly evident in the b1/ brain
(Figures 1H and 1I). Microtubule-associated protein 2 immuno-
histochemistry and Bielschowsky’s silver staining demonstrated
widespread losses of dendritic processes (Figure 2A) and white
matter axonal projections in these mutant mice (Figure 2B), sug-
gesting that absence of b1 causes loss of neurons and neuronal
processes.
To investigate the effects of b1 loss on central nervous system
(CNS) glia, we examined oligodendrocytes by immunohisto-
chemistry using the adenomatous polyposis coli antibody, and
found a 75–80% loss of oligodendrocytes at P14 (Figure 2C;
Figure 2. AMPKb1-Deficient Mice Demon-
strate both Neuronal and Glial CNS Deficits,
Seizures, and Reduced GABA Receptor
Phosphorylation
(A–D) Microtubule associated protein 2 (MAP2)
immunohistochemistry showing dendrites (A),
silver staining showing axonal tracts (B), adeno-
matous polyposis coli (APC) immunohistochem-
istry showing oligodendrocytes (C), and myelin
basic protein (MBP) immunohistochemistry
showing myelination (D) in the P14 brain.
(E) Electron microscopic analysis of P14 b1/
optic nerves.
(F) Quantification of GFAP+ cells in WT and b1/
brains; *p = 0.01; **p = 0.002. Error bars indicate
SD.
(G) Immunohistochemistry of the forebrain of
E18.5 WT and b1/ embryos using GFAP anti-
body. LV, lateral ventricle; arrow heads indicate
migrating GFAP+ astroglia.
(H) Quantitation of GFAP+ migrating astroglia in
E18.5 WT and b1/ brains. #p = 0.006. Error
bars indicate SD.
(I) EEG showing three seizure episodes recorded
for 30 min in P14 b1/ mice. The trace of one
episode is enlarged at the bottom for clarity.
(JandK) (J) ImmunohistochemistryofWTandb1/
P14 brain sections and (K) Western blot analysis




(L) Quantification of signal intensities in (K).
Figure S3B). This loss caused severe
hypomyelination throughout the brain,
which was particularly evident in the
corpus callosum and striatum (Figure 2D;
Figure S3C). Consistent with the deficit in
oligodendrocytes, the b1/ optic nerve
was translucent and 30% thinner than
WT nerve (Figure S3D). Electron micro-
scopic analysis demonstrated severe hypomyelination of mutant
P14 optic nerve axons (Figure 2E).
Astrocyte maturation occurs later in development, and was
difficult to study due to the early lethality of the b1/ animals.
We performed immunohistochemistry on P14 brains using anti-
bodies to GFAP, an intermediary filament enriched in differenti-
ated astrocytes (Cahoy et al., 2008) and brain lipid binding
protein (BLBP), which is expressed in neural progenitors, radial
glia, and immature/differentiating astrocytes (Domowicz et al.,
2008; Hegedus et al., 2007). The results showed that, in addition
to extensive astrogliosis in b1/ mice, there was an increased
number of astrocytes throughout the brain (Figure 2F;
Figure S4A). Moreover, astrocytes in P14 dentate gyrus of WT
animals expressed low levels of GFAP along with BLBP, whereas
astrocytes in b1/ mice expressed similar levels of BLBP, but
higher levels of GFAP (Figure S4B). At E18.5, consistent with
previous findings (Barnabe´-Heider et al., 2005), very few
GFAP+ cells were observed in WT mice; however, b1/ brain
contained many GFAP+ migrating astrocytes (Figures 2G and
2H), suggesting premature astrocytic differentiation of glial
precursors in these mice. Together, these results suggest that,258 Developmental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc.
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dendrocytes, this was accompanied by an increased number
of fully differentiated astrocytes.
AMPK-Directed GABAB Receptor Phosphorylation
Is Reduced In Seizure-Prone b1/ Mice
The extensive brain hypomyelination in b1/ mice, along with
their notable tremor and abnormal behavior, prompted us to
monitor them for seizure activity. Electroencephalogram record-
ings revealed spontaneous electrographic seizures in mutant
animals that usually recurred within less than 10 min
(Figure 2I). The seizures in these mice could result from the
paucity of oligodendrocytes and resulting decreased in myelin-
ated CNS fibers, the severe brain malformations, abnormal
energy homeostasis in the brain, or perhaps through decreased
inhibitory neuron activity.
GABA is the major inhibitory neurotransmitter in mammalian
brain, and it exerts its slow, prolonged effects via the GABAB
receptor, which is made up of two subunits, R1 and R2. Interest-
ingly, phosphorylation of the R2 subunit by AMPK at Ser783, acts
to stabilize GABAB activation of inwardly rectifying K
+ channels
and decrease synaptic activity (Kuramoto et al., 2007). Distur-
bances of GABA+ neurons, either through selective loss of these
neurons or via hypophosphorylation of the GABAB R2 receptor,
could facilitate seizure propensity. Immunohistochemistry of
P14 brain showed that the loss of GABAergic neurons was
similar (40%) to the loss of total neurons in b1/ P14 brain
(data not shown). However, immunohistochemical as well as
Western blot analysis using a GABAB-R2 pSer
783-specific anti-
body revealed that the R2 receptor was hypophosphorylated in
b1/ brain (Figures 2J–2L). Together, these results suggest
that loss of AMPK activity could interfere with proper
GABAergic signaling, potentially contributing to abnormal elec-
trical activity in the b1/ postnatal brain.
AMPKb1/ Neural Stem and Progenitor Cells Show
Defective Proliferation, Differentiation,
and Unregulated Apoptosis In Vivo
The deficits in multiple cell lineages in the brain suggest that
developmental processes were adversely affected by b1 defi-
ciency. We examined mice at a number of embryonic and peri-
natal ages, and found that E18.5 b1/ embryos were similar in
body size to WT embryos; however, the b1/ brain was
50% smaller (Figures S5A–S5D). To determine whether the
decreased size and cell number were due to abnormalities in
proliferation and/or apoptosis, we first counted the number of
cycling cells using Ki67 immunohistochemistry. We found
22.22 ± 4.66% less Ki67-positive cells around the lateral ventri-
cles in b1/ brain (Figure 3A). To investigate this cell cycle
defect, we pulse-labeled b1/ E14.5 embryos with bromodeox-
yuridine (BrdU) for 1 hr and performed immunohistochemistry
with antibodies against BrdU, which marks cells in S-phase,
phospho-histone H3 (PH3), which detects cells in M-phase, and
Ki67, which detects all actively cycling cells. We observed a
similar labeling index (proportion of cells in S-phase [(BrdU+)/
total cycling cells (Ki67+)]) in WT and b1/ forebrain (WT:
32.83 ± 6.66 versus b1/:33.46 ± 4.25) (Figure 3B). However,
the number of cells in mitosis (PH3+ cells) in mutant E14.5 fore-
brain (Figure 3C), as well as in P7 dentate gyrus and cerebellumDevelopm(Figures S5E–S5G), were significantly reduced, suggesting that
the cell cycle defect occurs after DNA synthesis.
Increased apoptosis could also be responsible for the
decreased numbers of neurons and glia, and often occurs in
response to abnormalities in cell cycle progression. We found
large numbers of apoptotic cells by cleaved caspase 3 immuno-
histochemistry in b1/ E14.5 forebrain (Figure 3D) and P7 cere-
bellum (Figure S5H). Although a few apoptotic cells were present
in the proliferative Sox2-positive ventricular zone, the majority
were found in the nestin-positive subventricular zone, particu-
larly in the intermediate zone and subplate of the mutant fore-
brain (Figures 3E and 3F). Double immunolabeling with BrdU
and cleaved caspase 3 antibodies confirmed that the majority
of apoptotic b1/ NPCs reside outside the BrdU-positive zone
(Figure 3G). As cells that aberrantly exit cell cycle often undergo
apoptosis, we examined cell cycle exit of b1/ NPCs. E14.5
embryos were labeled with BrdU for 24 hr, and double immuno-
labeling with BrdU and Ki67 antibodies was performed. The frac-
tion of BrdU-positive cells that were Ki67 negative represents the
cells that exited cell cycle during the labeling period. Although, it
appeared that a higher number of BrdU-positive cells were
present outside the subventricular zone in the b1/ brains
(Figure 3I), the majority of these cell were Ki67 negative, but
cleaved caspase 3 positive (Figure 3J), suggesting that a defect
after S phase is responsible for the massive apoptosis of b1/
NPCs. Moreover, we found increased numbers of apoptotic
Tuj1-positive immature neurons and Olig2-positive oligodendro-
cyte precursors, indicating that b1/ neural precursors undergo
apoptosis as they migrate and differentiate into neurons and
oligodendrocytes (Figures 3K–3L). In contrast, no cell death
was observed in the astrocyte population at P7 (Figure 3M) or
at E18.5 (data not shown).
Although the normal body size of b1/ embryos suggests that
there were minimal cell losses in other tissues, the ubiquitous
expression of AMPK prompted us to examine whether defects
in proliferation and apoptosis could be detected in other regions
of the body. We performed pHistone H3 and cleaved caspase 3
immunohistochemistry on sections of E14.5 embryo body, liver,
and interdigital junctions. Unlike b1/ embryonic brain, the
number of proliferating and apoptotic cells in these b1/ tissues
was similar to WT embryo tissues (Figures S6A–S6D). Collec-
tively, these results suggest that loss of the AMPKb1 subunit
leads to proliferative defects and unregulated apoptosis specif-
ically in the progenitors of the developing brain.
Defects in AMPKb1/ NPCs Are Cell Autonomous
AMPK is involved in central energy metabolism, and the devel-
oping brain is sensitive to metabolic imbalances. Thus, it was
important to determine whether the brain anomalies in the
b1/ animals were due to global metabolic abnormalities, or
whether they were cell autonomous to NPCs. While global meta-
bolic problems would likely cause deficits in multiple tissues, to
clearly address this issue, we isolated MEFs and cultured neuro-
spheres from E12.5 telencephalon from b1/ and WT embryos.
In response to energy deprivation, AMPK increases mitochon-
drial respiration and glucose transporter expression. We exam-
ined both glucose transporter expression and basal as well as
maximal oxygen consumption, and found that they were similar
in b1/ and WT NPCs and MEFs (Figures S7A–S7C).ental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc. 259
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AMPK Regulates Mammalian Brain DevelopmentFigure 3. Loss of b1 Results in Neural Stem/Progenitor Cell Developmental Defects
(A–D) Immunohistochemistry of the E14.5 forebrain with antibodies against Ki67 (red) (A), BrdU (green) and Ki67 (red) (B), phosphohistone H3 (red) (C), and
cleaved caspase 3 (red) (D).
(E and F) TUNEL staining (red) in conjunction with immunohistochemistry using Sox2 antibodies (green) (E) or nestin antibodies (green) at E14.5 (F). Inset in (F)
shows magnified view of TUNEL/Nestin double+ apoptotic neural precursors.
(G) Immunohistochemistry using BrdU (green) and cleaved caspase 3 (red) antibodies 1 hr after BrdU injection.
(H) A cartoon illustrating the different layers of the embryonic forebrain.
(I and J) (I) Immunohistochemistry using BrdU (green) and Ki67 (red) antibodies 24 hr after BrdU injection and (J) BrdU (green) and cleaved caspase 3 (red) anti-
bodies 24 hr after BrdU injection.
(K–M) Immunohistochemistry of E14.5 WT and b1/ brain using Tuj1 (green) and cleaved caspase 3 (red), (L) E18.5 brains using Olig2 (green) and cleaved cas-
pase 3 (red), and (M) P7 brains using GFAP (green) and cleaved caspase 3 (red) antibodies to detect apoptotic cells. Inset in (K) shows colocalization of Tuj1 and
cleaved caspase 3 in migrating neurons.
(N) Quantitative analysis of apoptotic neural cells. DAPI staining (blue) was used to highlight the nuclei. *p < 0.001. Error bars indicate SD.To investigate whether the proliferation and apoptosis defects
observed in b1/ NPCs in vivo were cell autonomous, we
cultured neurospheres and found that b1/ neurospheres
were significantly smaller in diameter (Figure 4A; Figure S7D)
and produced fewer numbers of secondary and tertiary neuro-
spheres (Figure S7E). Direct cell counting revealed that growth
and self-renewal capacity of b1/ NPCs was severely impaired260 Developmental Cell 16, 256–270, February 17, 2009 ª2009 Els(Figures 4B and 4C). The proliferative rate of b1/ NPCs was
examined using a 5-(and-6)-carboxyfluorescein diacetate, suc-
cinimidyl ester (CFSE) washout experiment (see Experimental
Procedures for details). Flow cytometric analysis of mean fluo-
rescence intensities of CFSE-labeled cells at 0 and 96 hr re-
vealed that b1/ NPCs proliferate at about half the rate of WT
NPCs (Figure 4D). We also used propidium iodide (PI) stainingevier Inc.
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AMPK Regulates Mammalian Brain DevelopmentFigure 4. AMPKb1 Loss Results in Cell-Autonomous NPC Defects
(A–C) Photomicrographs of telencephalic neurospheres cultured for 48 hr. Neurospheres were assayed for growth (B) and self-renewal (C). 1 NS and 2 NS,
primary and secondary neurospheres, respectively. Error bars indicate SD.
(D) WT and b1/ NPCs were incubated with CFSE dye and the fluorescence intensity of the cells was measured at 0 and 96 hr. The numbers in parenthesis are
mean fluorescence intensities.
(E and F) (E) PI staining of unfixed WT and b1/ neurospheres and quantitative analysis (F) of apoptosis of b1+/+, b1+/, and b1/ NPCs; *p < 0.005. Error bars
indicate SD.
(G) Quantification of immunohistochemical results obtained from in vitro differentiation of b1+/+, b1+/, and b1/ neurospheres showing percentage of neurons
(Tuj1), oligodendrocytes (O4), and astrocytes (GFAP). *p < 0.001. Data are representative of at least three independent experiments. Error bars indicate SD.to evaluate the extent of cell death in these cultured neuro-
spheres, and found that an increased number of b1/ NPCs
were PI positive (WT: 23.87 ± 3.33% versus b1/: 50.95 ±
7.55%) (Figures 4E and 4F), indicating that cell-intrinsic defects
lead to the abnormalities observed in these mutant NPCs.
To gain insight into how b1 deficiency causes the differential
loss of specific CNS cell types, the multilineage differentiation
potential of these neurospheres was examined. The b1/ neu-
rospheres produced fewer Tuj1-positive neurons (55.0 ±
8.25%) and O4-positive oligodendrocytes (60.45 ± 2.5%), but
similar numbers of GFAP-positive astrocytes (Figure 4G; Figures
S8A–S8C). However, b1/ astrocyte differentiation was not
normal. Immunocytochemistry with antibodies to BLBP (imma-
ture astrocyte marker), GFAP, and Aquaporin4 (mature astrocyte
markers) (Bachoo et al., 2004; Cahoy et al., 2008) showed that an
increased number of b1/ astrocytes lost BLBP expression and
displayed robust GFAP and Aquaporin4 expression (Figures
S8D–S8G), indicating that they prematurely differentiate in vitro
as they do in vivo.
Finally, the severe cerebellar defects in b1/ animals promp-
ted us to examine cultured cerebellar granule cell precursorsDevelopfrom P2 animals. We found that reaggregate formation, as well
as neurite projection, was severely impaired in the b1/ precur-
sors (Figure S9A). We also observed that 60%–70% of NeuN+
b1/ reaggregates were apoptotic (Figures S9B and S9C). In
sum, these results indicate that cell-autonomous defects caused
by b1 deficiency result in aberrant proliferation and/or cell fate
determination of neural precursors.
AMPKb Subunits Play Functionally Distinct
Roles in NPCs
The abnormalities in b1/ NPCs are caused by cell-intrinsic
mechanisms rather than by an altered global metabolic state in
these mutant mice. To understand why b1 deficiency results in
such devastating NPC defects, we performed Western blot anal-
ysis on b1/ neurospheres, and found that pAMPK was almost
absent, while pACC (a canonical target of AMPK) was reduced
by 50% (Figure 5A). The low AMPK activity in NPCs prompted
us to further investigate why the highly related AMPKb2 subunit
cannot complement the b1 mutation in these cells. We examined
their expression and subcellular localization using an antibody
that recognizes the C terminus of both b subunits, and foundmental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc. 261
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NPCs (Figure S10A). While b2 expression in b1/ NPCs was
increased (Figure S10A), it was obviously insufficient to compen-
sate for loss of b1 function. Subcellular fractionation studies
showed that active AMPK was reduced in both the cytoplasmic
and nuclear fractions of b1/ NPCs (Figure S10B). Interestingly,
immunocytochemistry using b1 or b2 N-terminal-specific anti-
bodies (Figure S10C), as well as Western blot assays using the
Figure 5. Expression of b1, but not b2, Rescues b1/ NPC
Phenotypes
(A) Immunoblot analysis of NPC lysates using phospho-AMPKThr172, total
ACC, and phospho-ACCSer79 antibodies. AMPKb1/ NPCs were infected
with lentivirus expressing GFP (control), b1, b2, or constitutively active (ca)
AMPKa2, while WT NPCs were infected with dominant negative (dn) AMPKa2,
and the growth rate (B), self-renewal capacity (C), and number of apoptotic
cells (D) were monitored; #p < 0.05. Data are representative of three indepen-
dent experiments. Error bars indicate SD.262 Developmental Cell 16, 256–270, February 17, 2009 ª2009 Elsecommon b1/b2 C-terminal-specific antibody, showed that b1
was distributed throughout the cell, whereas the b2 subunit
was primarily cytoplasmic (Figures S10D and S10E). Moreover,
in WT NPCs, immunoprecipitated AMPK complexes captured
with AMPKa1/2 antibody contained significantly more b1 than
b2 (Figures S10F and S10G). Interestingly, the absence of the
b1 subunit in NPCs resulted in lower levels of a subunits,
presumably reflecting decreased stability of the catalytic
subunits in cells lacking b1 (Figure S10B).
The widespread cellular distribution of the b1 subunit, particu-
larly in the nucleus, may imbue it with functions that are not
shared by b2. Expression of His-tagged human b1 or b2 by
lentivirus (Figure S10H) demonstrated that reintroduction of
b1 rescued the growth (Figure 5B), self-renewal (Figure 5C),
and apoptosis (Figure 5D; Figure S10I) defects of b1/ NPCs,
whereas the b2 subunit had no effect. To definitively prove that
AMPK activity is necessary for regulated proliferation of NPCs,
we expressed constitutively active (ca) and dominant-negative
(dn) AMPKa2 mutants in b1/ and WT NPCs. We found that,
while caAMPK partially rescued the self-renewal and apoptosis
defects of b1/ NPCs, dnAMPK severely reduced self-renewal
and caused catastrophic death of WT NPCs (Figures 5C and 5D).
These results indicate that AMPK is a crucial regulator of NPC
growth, and that its activity is uniquely dependent on the b1
subunit in NPCs.
AMPK Directly Phosphorylates Rb to Regulate
NPC Cell Cycle
The cell-autonomous defects in NPC growth caused by loss of
b1 prompted us to investigate the mitogen-activated protein
kinase (MAPK; Erk1/2) and PI3 kinase signaling (Akt) pathways,
which are crucial for NPC proliferation, survival, and differentia-
tion. However, we found that these pathways were normal in
b1/ NPCs (Figures S11A and S11B), suggesting that abnor-
malities in other effectors are responsible for the deficits in
b1/ NPCs. Other molecules central to NPC health, such as
GSK3b, which phosphorylates and destabilizes N-Myc (tran-
scription factor for D-type cyclins) (Galderisi et al., 2003; Kenney
et al., 2004), N-Myc, cyclin D1 and D2, and the cell cycle inhibi-
tors p16, p18, p21, and p27, were all expressed at normal levels
in b1/ NPCs (Figures S11C and S11D). Another critical regu-
lator of cell growth is p53, which is phosphorylated at Ser15 by
AMPK (Jones et al., 2005), was also unaltered in b1/ NPCs
(Figure S11D). Collectively, these data suggest that other effec-
tors or cell cycle regulators downstream of the cyclins and cell
cycle inhibitors must account for the b1/ NPC deficits.
Despite the seeming normalcy of most cell cycle regulators in
b1/ NPCs, the striking resemblance of the brain abnormalities
in b1-deficient mice with those observed in animals lacking
N-Myc (Knoepfler et al., 2002), cyclin D1/D2 (Ciemeryc et al.,
2002), Rb (Lee et al., 1992), and Rb family proteins (McLear
et al., 2006) prompted us to examine the cyclin downstream
target, Rb. Rb is exquisitely regulated by multiple phosphoryla-
tion events, and we noticed, in searching the Phosphosite data-
base (www.phosphosite.org), that one of the multiple Rb phos-
phorylation sites, Ser804 (Ser811 in human), resembled the
AMPK consensus phosphorylation site (Figure 6A). Immunoblot
analysis using antibodies specific for Rb phosphoSer804 and
pan Rb antibodies revealed that phosphorylation of Ser804 isvier Inc.
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Rb or in phosphorylation at another site (Ser780) was observed,
suggesting that Ser804 is specifically hypophosphorylated in
b1/ NPCs. The antibody used in our study recognizes both
Ser800 and Ser804. However, since only the Ser804, and not the
Ser800, conforms to the AMPK consensus site, we believe that
Ser804 is the likely residue phosphorylated by AMPK, and will
be used in the text henceforth. Our mutagenesis studies (see
subsequent text) further reinforce this view.
The CDK-cyclin D complex is known to phosphorylate Rb at
Ser804. Thus, the hypophosphorylation at this site in b1/
NPCs could result from an indirect effect on CDK4/6 activity or
a direct effect of AMPK on Rb. CDK4/6, which exist in complexes
with cyclinD1/D2, were immunoprecipitated using cyclin D1/2
antibodies, and the activity was measured by nonradioactive
in vitro kinase assays using bacterially produced Rb fusion
protein (residues 701–928) as the substrate. We found that
CDK4/6 activity from b1/ and WT NPCs was equivalent
(Figure 6C), indicating that b1 deficiency did not affect CDK
activity. To test whether AMPK directly phosphorylates Rb, we
immunoprecipitated the AMPK holoenzyme (a/b/g hetero-
trimers) using anti-AMPKa1/2 antibody from WT NPCs. In vitro
kinase assays using this immunoprecipitated AMPK enzyme
(or cyclin/CDK4/6 complex, control), and the Rb protein
mentioned above, showed that AMPK directly phosphorylated
Rb at Ser804, and that this modification could be inhibited by
the AMPK inhibitor, compound C (Figure 6D).
In proliferating cells, growth factor signaling promotes CDK-
dependent phosphorylation of Rb to inhibit it from sequestering
the E2F transcription factors. As a consequence of the high level
of hypophosphorylated Rb in b1/ NPCs, the amount of E2F1
sequestered by Rb should be higher in these cells. Rb was
immunoprecipitated from WT and mutant NPCs, and Western
analysis using anti-E2F1 antibody showed significantly more
Rb-E2F1 complexes in b1/ NPCs (Figures 6E and 6F), sug-
gesting that aberrant regulation of the Rb-E2F1 complex is at
least partially responsible for the b1/ NPC deficiencies.
b1/ NPCs Display Defects in the G2M Phase
of the Cell Cycle
The Rb-E2F complex plays multiple cellular roles, including
serving as a gate keeper of the G1-S restriction point, the
G2-M phase, cell cycle exit, cellular differentiation, and regula-
tion of apoptotic cell death (Burkhart and Sage, 2008; Rigberg
et al., 1999; Naderi et al., 2002; Yen and Sturgill, 1998; Niculescu
et al., 1998). Many of these defects are present in b1/ NPCs,
and our previous analysis demonstrated alterations in cell prolif-
eration. The abnormal regulation of Rb in these cells prompted
us to perform flow cytometric analysis to examine cell cycle
progression in these cells. In comparing b1/ and WT NPCs,
we found comparable numbers of cells in S phase (WT:
16.47 ± 4.7%; b1/: 18.06 ± 3.95%), less b1/ cells in G1
(WT: 71.5 ± 6.5%; b1/: 58.25 ± 3.25%; p = 0.005), and almost
twice as many b1/ cells in G2M phase (WT: 12.12 ± 1.7%;
b1/: 22.56 ± 1.95%; p = 0.001) (Figures S12 and S13), indi-
cating that b1/ cells have defects that prevent them from
properly exiting or reentering the cell cycle.
To firmly establish a direct connection between these cell
cycle defects and the AMPK-Rb signaling axis, we examinedDevelopthe levels of pAMPK and pRb in b1/ NPCs expressing b1, b2,
caAMPK, or dnAMPK. b1/ NPCs expressing caAMPK or b1,
but not b2, showed increased levels of pAMPK, pRb, and
pACC levels (Figures S14A–S14D), while WT NPCs expressing
dnAMPK showed significantly decreased Rb and ACC phosphor-
ylation (Figures S14C and S14D). Together, these results indicate
the importance of the AMPK-Rb signaling axis in NPC growth,
a pathway that is largely regulated through the b1 subunit.
The highly orchestrated, cyclical phosphorylation of Rb
throughout the cell cycle makes Rb overexpression studies diffi-
cult. Nevertheless, we generated lentiviruses expressing WT
Rb, Rb(S804A), removing the critical phosphorylation site, and
Rb(S804E) and Rb(S804D), potentially creating phosphomimet-
ics. These lentiviruses were used to examine whether an Rb
phosphomimetic mutant could rescue the b1/ NPC growth
defect, and whether a phosphorylation-resistant Rb would
cause growth defects in WT NPCs. We infected WT NPCs with
lentivirus expressing GFP (control), WT Rb, or Rb(S804A), and
b1/ NPCs with lentivirus expressing GFP (control), WT Rb,
Rb(S804A), Rb(S804E), or Rb(S804D). The cells were counted
24 hr after infection. Both WT Rb and Rb(S804A) caused signif-
icant growth reduction in WT NPCs. b1/ NPCs expressing
GFP, WT Rb, or Rb(S804A) showed poor growth; however, those
expressing the phosphomimetic mutants, showed improved
growth (Figure 6G). We continued to observe these cells and
found that, by 48 hr, the neurospheres expressing Rb(S804E)
or Rb(S804D) stopped growing and began to look unhealthy,
suggesting that constitutive phosphorylation of Rb at this site
may prevent cells from reentering cell cycle.
Previous analysis showed that b1/ NPC cell cycle progres-
sion was blocked at the G2M phase. We therefore investigated
whether b1/ NPCs expressing Rb(S804E) or Rb(S804D) could
now transit the G2M stage. Flow cytometric analysis performed
on cells 24 hr after lentiviral infection showed that b1/ NPCs
expressing WT Rb or Rb(S804A) had 27% cells in G2M, whereas
b1/ NPCs expressing Rb(S804E) or Rb(S804D) had 16% cells
in G2M (Figure 6H; Figures S15–S19). Interestingly, WT NPCs
expressing Rb(S804A) had more cells (22%) in G2M than those
expressing GFP (10%) (Figure 6H; Figures S20 and S21). These
results indicate that the hypophosphorylation of Rb at Ser804 is
responsible for the G2M defect in b1/ NPCs, as a phosphomi-
metic Rb mutant can partially restore the ability of these cells to
transit G2M. It is interesting that, although Rb is phosphorylated
at 19 different Ser/Thr residues, many of which could serve over-
lapping as well as specific functions, the phosphorylation of Rb
at Ser804 appears to play an important role in G2M phase and/
or cell cycle exit in NPCs.
Stem Cell Growth Factors as well as Metabolic
Perturbations Activate AMPK to Promote NPC
Proliferation
We extended our studies to explore whether WT NPC growth
was enhanced by activation of AMPK via genetic or physiolog-
ical stimuli. Constitutively active AMPK not only enhanced
proliferation of WT NPCs (Figure 6I), but also caused a signifi-
cant increase in Rb phosphorylation (Figure 6J). Accordingly,
the proportion of E2F1 sequestered by Rb was reduced in
WT NPCs expressing caAMPK, whereas dnAMPK caused
significantly more E2F1 sequestration (Figure 6K). It is intriguingmental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc. 263
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AMPK Regulates Mammalian Brain DevelopmentFigure 6. AMPK Phosphorylates Rb to Regulate Rb-E2F Interaction
(A) AMPK consensus sequence (top) and AMPK phosphorylation site in ACC and potential site found in Rb (bottom).
(B) Immunoblot analysis of b1/ NPC lysates using pRbSer800/804, pan Rb, pRbSer780, and tubulin antibodies. Data are representative of three independent
experiments.
(C and D) Nonradioactive kinase assay: CDK4/6 complex immunoprecipitated using cyclin D1/D2 antibodies from WT and b1/NPCs (C) and AMPK holoenzyme
immunoprecipitated using AMPKa1/2 antibody from WT NPCs used to phosphorylate recombinant Rb protein (residues 701–928). Phosphorylation was moni-
tored by immunoblot using phosphor-Rb800/804 antibody. Data are representative of three independent experiments.
(E and F) Immunoprecipitation of NPC lysates with pan Rb antibody, followed by Western blot with E2F1 antibody and densitometry, showed the increased
amount of E2F1-Rb complexes in b1/ NPCs.
(G) Proliferation assay of WT and b1/ NPCs expressing GFP or the indicated Rb proteins. Data are representative of two independent experiments; *p < 0.005.
Error bars indicate SD.
(H) Flow cytometric analysis of NPCs expressing GFP or Rb proteins displaying the percentage of cells in G2M phase. FACS data are available in the Supple-
mental Data (Figures S12–S13 and S15–S21).
(I) Proliferation assay of WT NPCs expressing GFP, constitutively active (ca) AMPK, b1, or b2 subunits. Data are representative of three independent experiments.
Error bars indicate SD.
(J) Immunoblot analysis of WT NPCs expressing caAMPK using pAMPKaThr172 and pRbSer800/804, and pan AMPKa and Rb antibodies.
(K) Immunoprecipitation assay showing the level of E2F1 bound to Rb in NPCs expressing GFP (control), caAMPK, or dnAMPK; *p < 0.005.264 Developmental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc.
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caused a distinct increase in WT NPC growth (Figures 5B
and 6I), supporting its role in regulating AMPK-mediated NPC
proliferation.
The effects of AMPKb1 deletion on Rb phosphorylation led us
to consider whether the highly conserved AMPK signaling
pathway is fundamentally important for NPC responses to prolif-
erative signals, such as growth factors. We cultured WT NPCs in
the absence of growth factors for 2 hr (withdrawal phase) and
then added back epidermal growth factor (EGF) and fibroblast
growth factor (FGF) for 1 hr. Cells treated with growth factors
had increased levels of pAMPK and increased phosphorylation
of Rb at Ser804. However, when EGF and FGF were added to
cells treated with the AMPK inhibitor compound C, no increase
in pAMPK or pRb was observed (Figures 7A and 7B). Thus, it
appears that the failure of AMPK-directed phosphorylation of
Rb in b1/ NPCs, perhaps in response to endogenous growth
factors, results in defects in G2M phase as well as the aberrant
differentiation that leads to apoptosis.
AMPK is integrally involved in regulating cellular energy
homeostasis and is activated by low cellular ATP levels, such
as occurs by limiting oxygen or glucose supplies or exercise,
conditions that enhance proliferative capacity of stem cells
(Bu¨rgers et al., 2008; Fu et al., 2006; Stolzing et al., 2006). To
explore whether the proliferative effects of glucose restriction
are manifested through activation of the AMPK-Rb axis, we
monitored the growth of WT NPCs cultured in 2.5–25 mM (the
amount present in neurobasal medium) glucose for 48 hr. NPC
cell numbers were increased when grown in low-glucose
medium, with 5 mM glucose giving the highest growth rate
(Figure 7C). The NPC growth stimulation by low glucose was
not observed in cells treated with compound C, which severely
inhibited neurosphere growth. Furthermore, no effect on growth
by low glucose was observed in b1/ NPCs, consistent with
their lack of AMPK signaling (Figure 7D). Interestingly, there
was a small but consistent increase in the phosphorylation of
AMPK, Rb, and ACC at lower glucose concentrations (Figures
7E–7K). Remarkably, glucose limitation also reduced the propor-
tion of Rb-bound E2F1, whereas compound C treatment caused
higher levels of Rb sequestration of E2F1 (Figure 7L). Collec-
tively, our results demonstrate that, perhaps, growth factor
signaling, as well as other physiological/metabolic stimuli, utilize
the AMPK-Rb signaling pathway to modulate the growth and
differentiation of NPCs during mammalian brain development.
DISCUSSION
Rb Phosphorylation and AMPK in NPC Cell
Cycle Progression
In this study, we identify AMPK as an important kinase for Rb,
and show that loss of AMPK activity in AMPKb1-deficient
animals causes Rb hypophosphorylation and multiple NPC
defects. AMPK is a ubiquitously expressed kinase, with many
substrates that influences cellular as well as organismal energy
homeostasis. It is likely that the complex phenotype of the b1
mutant mice results from aberrant signaling from multiple
AMPK-regulated pathways. Although CDK4/6 can phosphory-
late Rb at Ser804 (Zarkowska and Mittnacht, 1997), the phos-
phorylation of this site is dramatically decreased in b1/DevelopmNPCs. Data concerning Rb phosphorylation in NPCs is scanty;
however, it is noteworthy that most mouse cells lacking two or
even three CDKs still proliferate (Malumbres et al., 2004; Berthet
et al., 2006; Barriere et al., 2007) and contain residual phosphor-
ylated Rb, providing further evidence that other kinases, such as
AMPK, must also phosphorylate Rb.
Despite the importance of Rb phosphorylation as a defining
regulatory event in G1 (Sherr, 2000; Massague´, 2004; Orford
and Scadden, 2008), b1/ NPCs with hypophosphorylated Rb
appear to enter S phase normally in vitro as well as in vivo. Rb
has 19 Ser/Thr residues that are potentially and transiently phos-
phorylated during various stages of the cell cycle, but informa-
tion concerning the roles of specific phosphorylation events
remains limited. In fact, how different kinases might contribute
to differential control of Rb, such as regulating its binding to
specific ligands, is an unresolved question (Mittnacht, 1998).
Rb, which remains hyperphosphorylated from late G1 through
the rest of the cell cycle, is now viewed as a transcriptional
cofactor (Burkhart and Sage, 2008). Current evidence indicates
that Rb hypophosphorylation causes not only G1 arrest, but
also arrest during the G2M transition (Burkhart and Sage,
2008; Rigberg et al., 1999; Naderi et al., 2002; Yen and Sturgill,
1998; Niculescu et al., 1998). It is important to note that func-
tional Rb is required specifically for the S and G2 phases in
mouse ES cells (Fluckiger et al., 2006). Furthermore, a number
of E2F1 target genes, such as Mad2 (Sotillo et al., 2007) and
SIL (Erez et al., 2008), control the spindle checkpoint during
mitosis. Functional complexes containing E2F and Rb are essen-
tial for repressing expression of these critical mitotic regulators
to maintain the G2M checkpoint (Polager and Ginsberg, 2003).
The decreased number of mitotic cells in the ventricular zone
of the b1/ brains, where neural stem cells undergo self-
renewal, together with the large number of apoptotic cells
outside the subventricular zone, where progenitor cells migrate
and differentiate, suggest that Rb phosphorylation at Ser804 by
AMPK is necessary for multiple aspects of NPC biology.
The enhanced growth of b1/ NPCs expressing phosphomi-
metic Rb mutants versus the growth suppression of WT NPCs
expressing phosphorylation-resistant Rb is intriguing. Earlier
studies demonstrated that introduction of phosphorylation-
resistant mutant Rb protein in many cell types can efficiently
suppress cell proliferation (Jiang and Zacksenhaus, 2002; Chang
et al., 1995; Roig et al., 2004). It appears from our results that
AMPK-dependent phosphorylation of Ser804 is crucial for
different phases of NPC cell cycle, particularly the G2M phase.
Caloric restriction, hypoxia, and exercise all reduce cellular
energy stores and stimulate AMPK activity. The potentiation of
NPC proliferation by glucose restriction or constitutively active
AMPK is consistent with the AMPK-dependent augmented neu-
rogenesis of adult neural stem cells observed in mice under
dietary restriction (Dagon et al., 2005). Interestingly, treatment
with the AMPK pharmacological activator, 5-Aminoimidazole-
4-carboxamide-1-b-riboside (AICAR), did not increase NPC
proliferation (data not shown). While we do not know why AICAR
was ineffective, it also exerts many AMPK-independent effects,
such as inhibition of mitochondrial respiratory chain complex I
(Guigas et al., 2007) and regulation of multiple metabolic
enzymes (e.g., fructose 1-6, bisphosphatase, glucokinase) (Vin-
cent et al., 1991, 1992). The potential of AMPK to couple nutritionental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc. 265
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AMPK Regulates Mammalian Brain DevelopmentFigure 7. Energy Restriction and Growth Factor Signaling Utilize the AMPK-Rb Axis to Enhance NPC Proliferation
(A and B) Immunoblot (A) and densitometric analysis (B) of WT NPCs using indicated antibodies after 2-hr growth factor stimulation in the presence or absence of
AMPK inhibitor compound C (CC; 5 mM).
(C and D) Proliferation assay of WT NPCs (C) and b1/ NPCs (D) cultured for 48 hr under glucose-limiting conditions (Cont = 25 mM glucose, which is the amount
in neurobasal medium). Data are representative of three independent experiments (#p = 0.07; *p% 0.005). Error bars indicate SD.
(E–K) Immunoblot (E) and densitometric analysis (F–K) using phospho-specific AMPKaThr172, RbSer800/804, ACCSer79, and pan AMPKa, Rb, and ACC antibodies.
AU, arbitrary units.
(L) Immunoprecipitation assay using Rb antibody and Western blot with E2F1 antibody from NPCs grown in the indicated glucose concentration in the absence or
presence of CC (5 mM).and stem cell proliferation/differentiation is an important new
avenue of exploration that will be enhanced by the identification
of more specific AMPK activators and inhibitors.
AMPK-Rb Signaling in Development and Tissue
Maintenance
AMPK activity is crucial for embryonic development, as demon-
strated by the stunted growth and reproductive failure in Arabi-
dopsis lacking AMPK activity (Baena-Gonza´lez et al., 2007),266 Developmental Cell 16, 256–270, February 17, 2009 ª2009 Elseand in the embryonic lethality in Drosophila lacking either
a (Lee et al., 2007) or b subunits (Spasic´ et al., 2008). The regu-
lation of Rb by AMPK is particularly intriguing in this regard, as
the Rb-E2F pathway is involved in fate specification and differen-
tiation of multiple cell types. Appropriate Rb function is neces-
sary for terminal differentiation of progenitor cells undergoing
maturation. In Caenorhabditis elegans, developmental defects,
rather than changes in cell proliferation, are the most striking
consequences of Rb-E2F malfunction (Heuvel and Dyson,vier Inc.
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AMPK Regulates Mammalian Brain Development2008). In mammals, the Rb-E2F pathway regulates fate and
differentiation of a number of cell types, including neurons (Lee
et al., 1992; Callaghan et al., 1999), cardiac stem cells (Papadi-
mou et al., 2005), adipocytes (Dali-Youcef et al., 2007; Fajas
et al., 2002), erythrocytes (Sankaran et al., 2008), and epithelial
cells (Wikenheiser-Brokamp, 2004). These cell fate choices
depend on the active transcriptional repression mediated by
Rb-E2F1 complexes (Weintraub et al., 1995) and by direct effects
of hypophosphorylated Rb on transcriptional regulators, such as
peroxisome proliferator-activated receptor-g (Fajas et al., 2002).
Finally, excess E2F activity due to Rb loss results in decreased
mitochondrial biogenesis and impaired erythroid differentiation
(Sankaran et al., 2008). Thus, the differentiation defects in b1/
brain are likely caused by the wide range of activities disrupted
by the altered levels of Rb-E2F complexes in NPCs.
The loss of axonal and dendritic processes in b1/ postnatal
brain is consistent with the neurodegeneration phenotype
observed in AMPK g (Tscha¨pe et al., 2002) and b subunit-defi-
cient (Spasic´ et al., 2008) Drosophila models. Interestingly, in
Drosophila, loss of the entire b subunit gene was functionally
equivalent to the loss of b subunit C-terminal exons, consistent
with our findings in mice. Thus, it appears that, besides being
required during embryonic differentiation, AMPK is also neces-
sary for maintaining the structural and functional integrity of
mammalian neurons. However, unlike the case in epithelial cells,
where the AMPK-LKB1 axis influences polarity (Lee et al., 2007;
Mirouse et al., 2007), we observed no morphological changes
reflective of altered neuronal polarity, nor did we observe an
altered distribution of the polarity proteins PAR3 or pPKCx
(Figures S5I–S5K). Why AMPKb1 deficiency causes specific
loss of neurons and oligodendrocytes, but not astrocytes, is
unclear; however, it should be noted that astrocyte differentia-
tion can proceed normally in the absence of Rb (Marino et al.,
2000). b1/ astrocytes do not differentiate normally, suggesting
that additional AMPK-modulated pathways are important in
these cells. On the other hand, it is tempting to speculate that
hypophosphorylation of Rb at Ser804 in NPCs might contribute
to the altered ratio of neural cells in vivo.
Finally, the identification of Rb as an AMPK substrate is
intriguing, because it raises the possibility that cell proliferation
and fate choice can be influenced by intracellular energy levels
through the actions of AMPK. In fact, AMPK, along with the other
components of the cellular energy sensing system, namely
NaMPT and SIRT1, have been recently shown to influence
muscle differentiation based on intracellular energy status (Fulco
et al., 2008). Future work will determine whether morphogens
and growth factors that orchestrate fate choice also activate
AMPK.
Importance of AMPK Subunit Composition
The inability of the b2 subunit to functionally compensate for
loss of b1 is surprising in light of their high homology and the
considerable physiologic redundancy observed between the
two a subunits (Viollet et al., 2003; Jørgensen et al., 2005).
This is highlighted by the increased NPC growth mediated by
overexpression of b1 but not b2. One important distinction
between these subunits is the failure of b2 to enter the nucleus,
where it could potentially promote AMPK phosphorylation of
Rb. b1 is also heavily phosphorylated; thus, it is also possibleDevelopmthat differential modifications of the two b subunits directly regu-
late AMPK substrate choice in a context-dependent manner.
For example, it is interesting that AMPK is required for adapta-
tion of nutrient-deprived cancer cells to hypoxia (Yun et al.,
2005; Laderoute et al., 2006; Nagata et al., 2003), and that
loss of AMPK activation sensitizes cancer cells to apoptosis
(Kim et al., 2007; Baumann et al., 2007). If AMPK is required
for cancer stem cell self-renewal as it is for NPCs, then AMPK
inhibitors could be useful chemotherapeutic agents.
Conversely, AMPK activators or dietary manipulation may be
useful in promoting adult neurogenesis in disorders where these
cells have been damaged, such as during radiotherapy or
chemotherapy.
EXPERIMENTAL PROCEDURES
Generation of AMPKb1 Mutant Mice
ES cells (clone RRR454) containing an AMPKb1 gene trap allele, was obtained
from Bay Genomics. Briefly, AMPKb1 gene trap ES cells were microinjected
into blastocysts derived from superovulated pregnant mice, and these blasto-
cysts were injected into pseudopregnant C57BL/6 females. Chimeric males
(129/Ola mixed background) were mated with C57BL/6 females, and germ
line transmission was confirmed by PCR genotyping of tail DNA. All proce-
dures were carried out in the Washington University animal care facility.
TUNEL Staining
Tunel staining was performed on frozen sections, per the manufacturer’s
instructions (Roche, Indianapolis, IN), and visualized with Cy3-streptavidin
and fluorescence microscopy.
In Vitro Culture of Neural Progenitors
Neurospheres were dissected from E12.5 CNS telencephalic lobes and
cultured in neurobasal medium supplemented with B27 and N2, as described
previously (Dasgupta and Gutmann, 2005). To assess NPC growth, 104 cells
from animals of each genotype were seeded in triplicate. At each time point,
resulting neurospheres were trypsinized and counted on a hemocytometer.
For self-renewal assays, single neurospheres were picked up by pipette and
neurosphere diameter was measured individually under microscope. Ten
similar-sized neurospheres of each genotype were triturated individually
before plating, and the number of resulting secondary neurospheres gener-
ated per primary neurosphere was counted after 6 days. Neurosphere diame-
ters were measured using Metamorph software. For NPC proliferation assay,
NPCs were labeled with CFSE, as previously described (Dasgupta and Gut-
mann, 2005). Briefly, NPCs were pulse labeled with 5 mM CFSE at 37C for
15 min, washed, and one-half of the cells were analyzed by FACS, while the
other half was analyzed after 4 days of growth. Detailed methods are available
in the Supplemental Data.
Nonradioactive In Vitro Kinase Assay
Nonradioactive in vitro kinase assay was performed as previously described
(Lee et al., 2007), with minor modifications. Briefly, WT NPCs were lysed
with MAPK buffer, and AMPK was immunoprecipitated from WT NPCs with
AMPKa1/2 antibody, washed with a buffer containing 10 mM Tris-Hcl (pH
7.5) and 0.5 M LiCl, and suspended in kinase buffer containing 0.5 mM ATP.
CyclinD1/D2 (associated with CDK4/6) was immunoprecipitated with cyclinD1
and cyclinD2 antibodies. Reactions were carried out at 30C for 1 hr by adding
RB-C fusion protein (residues 701–928; Cell Signaling Technology, Beverly,
MA) to the reaction mix. Reaction was terminated by adding 63 Laemmli buffer
and boiling for 5 min. Samples were resolved in 10% SDS-PAGE, and Western
blot analysis was performed with phospho-RbSer800/804 (Ser807/811 in human)
antibody (Cell Signaling Technology).
Quantitative Analysis of Cell Numbers and Statistical Methods
Student’s t test was used to calculate statistical significance with p < 0.05 rep-
resenting a statistically significant difference. For in vivo quantitative analysis
of cell numbers, five square regions with identical areas were demarcatedental Cell 16, 256–270, February 17, 2009 ª2009 Elsevier Inc. 267
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Metamorph software, and cells were counted in each region. The sections
were plane-matched and photographed digitally on a Nikon microscope.
Sections from three mice of each genotype were used for manual cell count-
ing. Brain size was measured using NIH Image J software. Pixels occupying
the area of a dorsal view of the brain were quantitated and represented as brain
size. Densitometric analysis of immunoblots was performed using GelPro
analyzer software. Error bars in all figures indicate SD.
Detail methods for genotyping, RT-PCR and primer sequences, seizure
study, electron microscopy, tissue preparation, immunohistochemistry,
immunoprecipitation, subcellular fractionation, Western blot analysis, cell
culture, AMPK activity assay, cell respiration studies, as well as plasmids
and viruses are available in the Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, twenty-
one figures, Supplemental References, and one movie and can be
found with this article online at http://www.cell.com/devlopmental-cell/
supplemental/S1543-5807(09)00033-1/.
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